期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 434, 期 1-2, 页码 106-114出版社
ELSEVIER
DOI: 10.1016/j.ijpharm.2012.05.030
关键词
Calcein; Human growth hormone; Microneedle; Iontophoresis; Programmable drug delivery; Transdermal
The objective of this work was to modulate transdermal drug delivery by iontophoresis though skin microchannels created by microneedles. Calcein and human growth hormone were used as a model small and large molecule, respectively. In vitro permeation studies were performed on porcine ear skin under three different settings: (a) modulated iontophoresis alone, (b) pretreatment with microneedles and (c) combination of microneedles pretreatment and modulated iontophoresis. For modulated iontophoresis, 0.5 mA/cm(2) current was applied for 1 h each at 2nd and 6th hour of the study. Methylene blue staining, calcein imaging and pore permeability index suggested maltose microneedles created uniform microchannels in skin. Application of iontophoresis provided two peaks in flux of 1.04 mu g/(cm(2) h) at 4th hour and 2.09 mu g/(cm(2) h) at 8th hour of study for calcein. These peaks in flux were significant higher when skin was pretreated with microneedles (p < 0.05). Similarly, for human growth hormone, modulation in transdermal flux was achieved with combination of microneedles and iontophoresis. This combination also provided significant increase in cumulative amount of calcein and human growth hormone delivered as compared to microneedles or iontophoresis alone (p < 0.05). Therefore, iontophoresis can be used to modulate drug delivery across skin microchannels created by microneedles. (c) 2012 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据